361
Animal Model of Elite Controlled Infection
C Apetrei, Thaidra Gaufin*, D Mandell, R Gautam, C Monjure, M Pattison, M Barnes, J MacFarland, C Tatum, and I Pandrea
Tulane Natl Primate Res Ctr, Covington, LA, US
Background: Understanding the mechanism of infection
control in elite controllers (EC) may shed light on the correlates of control
of disease progression in HIV infection. However, research on human EC is
limited to studies at late time points in infection, after control is achieved,
on limited samples collected at random time points and limited access to
tissues. These limitations have prevented development of a clear understanding
of the mechanisms of EC HIV infection. In the existing animal models of EC
infection, control is not achieved in all cases, which prevents the study of
early events that may drive EC infection. We developed an animal model for EC
HIV infection.
Methods: We infected 5 rhesus macaques with SIVagm.
Viral loads in blood and tissues, viral evolution, dynamics of major immune
cell populations and subsets, and immune responses were followed as long as 6
years. CD8 cells were depleted using cM-T807.
Results: Acute SIVagm infection in rhesus
macaques is characterized by: high levels of viral replication and dramatic
mucosal CD4+ T cell depletion, both similar to pathogenic HIV-1/SIV
infections of humans and rhesus macaques, followed by complete control of SIVagm
replication, defined as: undetectable viral loads beginning 72 to 90 days
postinoculation and continuing through at least 6 years; negative polymerase
chain reactions for multiple SIVagm genes in peripheral blood
mononuclear cells, lymph nodes, and intestine; seroreversion; progressive
recovery of mucosal CD4+ T cells, with complete recovery by 4 years postinoculation;
normal levels of T cell immune activation, proliferation, and apoptosis; and no
disease progression. We also showed that control is independent of MHC types,
partial APOBEC restriction is not involved in SIVagm control in rhesus
macaques and experimental CD8 cell depletion in controlled SIVagm
infections of rhesus macaques resulted in transient rebounds of viral loads.
Conclusions: All SIVagm-infected rhesus
macaques demonstrated durable control of SIVagm infection. This
control was independent of MHC types and was most probably due to effective
cellular immune responses. SIVagm-infected rhesus macaques can be
used as an animal model of EC lentiviral infection, for studies that cannot be
done in HIV-infected patients: examine early events of infection in blood and
tissues, before the defining characteristics of EC are evident; determine if
viral persistence in a given host is due to low levels of viral replication or
latency; and selectively deplete different cellular subsets to assess their
contribution to the control of viral load.
|